Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 10/20/11 | 8-K | Current report filing |
|
6 | |
| 10/17/11 | 8-K | Current report filing |
|
6 | |
| 10/14/11 | SC 14F1 | Statement regarding change in majority of directors pursuant to Rule 14f-1 |
|
15 | |
| 10/14/11 | 8-K | Current report filing |
|
414 | |
| 10/07/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
11 |
| 08/15/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
11 |
| 05/05/11 | 4 | Moss David J |
|
2 | |
| 05/04/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
11 | |
| 03/02/11 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
21 | |
| 01/05/11 | UPLOAD | SEC-generated letter |
|
1 |
